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ABSTRACT
Moniliophthora perniciosa is the 
causative agent of witches’ broom disease, 
which devastates cacao cultures in South 
America. This pathogenic fungus infects 
meristematic tissues and derives nutrients from 
the plant apoplast during an unusually long-
lasting biotrophic stage. In order to survive, the 
fungus produces proteins to suppress the plant 
immune response. Proteins of the Pathogenesis 
Related 1 (PR-1)/CAP superfamily have been 
implicated in fungal virulence and immune 
suppression. The genome of M. perniciosa
encodes eleven homologues of plant PR-1 
proteins, designated MpPR-1 proteins, but their 
precise mode of action is poorly understood. In 
this study, we expressed MpPR-1 proteins in a 
yeast model lacking endogenous CAP proteins. 
We show that some members of the MpPR-1 
family bind and promote secretion of sterols 
whereas others bind and promote secretion of 
fatty acids. Lipid-binding by purified MpPR-1 
occurs with micromolar affinity and is 
saturable in vitro. Sterol binding by MpPR-1 
requires the presence of a flexible loop region 
containing aromatic amino acids, the caveolin-
binding motif. Remarkably, MpPR-1 family 
members that do not bind sterols can be 
converted to sterol binders by a single point 
mutation in the caveolin-binding motif. We 
discuss the possible implications of the lipid-
binding activity of MpPR-1 family members 
with regard to the mode of action of these 
proteins during M. perniciosa infections. 
Witches’ Broom Disease of cacao 
(WBD) is one of the most devastating plant 
diseases in Southern America, and a major 
threat to cacao production, resulting in 
extensive economic losses in affected countries 
(1, 2). WBD is caused by the basidiomycete 
fungus Moniliophthora perniciosa (3). This 
hemibiotrophic fungus has an atypical 
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prolonged biotrophic stage of up to 90 days, 
during which it slowly grows in the apoplast of 
infected plants, inducing conspicuous 
morphological alterations that culminate with 
the formation of anomalous structures called 
“green brooms”. These chlorotic and swollen 
shoots are formed as a consequence of a 
hormonal imbalance and intense 
reprogramming of the plant metabolism 
induced by the fungal infection (4, 5). The 
necrotrophic phase of the disease begins upon 
death of plant tissues, which are invaded by the 
proliferative mycelia. M. perniciosa also 
infects cacao flowers and fruits, causing 
swelling and abnormal ripening of the fruits 
and ultimately death of the infected tissues (1). 
A genome draft of M. perniciosa (6), a 
comprehensive transcriptomic analysis of the 
biotrophic stage of the interaction (4), and a 
series of functional analyses of M. perniciosa
proteins provided insights into this intriguing 
disease (7–10). 
Members of the CAP (Cysteine-rich 
secretory proteins, Antigen 5, and 
Pathogenesis-related 1) superfamily of 
proteins, also known as SCP/TAPS (Sperm-
Coating Protein/Tpx-1/Ag5/PR-1/Sc7)
proteins, are present throughout the eukaryotic 
kingdom (11, 12). In plants, pathogenesis-
related 1 (PR-1) superfamily members serve 
markers of an induced defense against 
pathogens (13). Interestingly, CAP proteins are 
abundantly expressed by human pathogenic 
nematodes such as Schistosoma mansoni and 
Necator americanus during infection, and were 
speculated to function as immunomodulators to 
inhibit host defense (14). A CAP protein from 
a single isolate of Fusarium oxysporum f. sp. 
lycopersici, which can cause disease on both 
tomato plants and immunodepressed mice, is 
important in the infection of the animal model. 
However, this protein is not essential for 
virulence on tomato (15). Gr-Vap1, a CAP 
protein from the potato cyst nematode 
Globodera rostochiensis, on the other hand, 
induces the loss of basal immunity to unrelated 
pathogens when heterologously expressed in 
plants (16). In addition, the knock-down of Gr-
Vap1 expression reduces the infectivity of 
nematode, indicating that this protein is 
important for pathogen-induced suppression of 
plant defense. An immunomodulatory function 
was also suggested for tablysin-15, a CAP 
protein from the horsefly Tabanus yao.
Tablysin-15 binds leukotrienes and free fatty 
acids and thereby might inhibit the 
proinflammatory effects of leukotrienes that are 
released from mast cells in the vicinity of the 
bite (17). 
The Saccharomyces cerevisiae CAP 
proteins, the Pry proteins (pathogen related in 
yeast) function to bind and export sterols and 
fatty acids out of the cells (18, 19). The sterol 
binding activity is conserved among many CAP 
superfamily proteins, since expression of 
human CRISP2, parasitic SmVAL4, or plant 
PR-1 rescues the lack of Pry function in yeast, 
and these proteins bind cholesterol in vitro (18,
20, 21). Expression of tablysin-15, however, 
does not rescue the sterol export phenotype but 
rescues export of fatty acids (19). The sterol 
and fatty acid binding and export function of 
the yeast CAP proteins is confined to the CAP 
domain, because expression of the CAP domain 
alone is sufficient to rescue the sterol and fatty 
acid export phenotype of a pry1 pry2 double
mutant, and the CAP domain of Pry1 alone 
binds sterols and fatty acids at distinct sites in
vitro (19, 22, 23). Sterol binding by Pry 
proteins requires the displacement of a flexible 
loop containing aromatic amino acids, termed 
the caveolin-binding motif (CBM) within the 
CAP domain, since point mutations within this 
motif abolish sterol export and binding, 
whereas fatty acid binding takes place in the 
groove between two parallel running helices, 
1 and 3 (19, 24). Taken together, these data 
indicate that CAP proteins may exert an 
immunomodulatory function through binding 
hydrophobic ligands, such as sterols or related 
small hydrophobic compounds and fatty acids 
and their derivatives such as leukotrienes (19, 
23, 25). 
The genome sequence of M. perniciosa
indicates the presence of 11 CAP family
members in this phytopathogen (6, 26). 
Furthermore, gene expression analyses 
revealed that some of M. perniciosa CAP
genes, termed MpPR-1 genes, are highly and 
specifically expressed during the green broom 
stage of WBD, and in germinating 
basidiospores (4, 26). These results suggest that 
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some MpPR-1 proteins function during the M. 
perniciosa infective process.
In this work, we examine whether 
MpPR-1 proteins have lipid-binding activity in
vivo, by complementing yeast Pry mutants, and 
in vitro, through sterol and fatty acid binding 
assays. Five of the ten MpPR-1 family 
members tested, MpPR-1c, MpPR-1d, MpPR-
1g, MpPR-1j and MpPR-1k complemented the 
defect in sterol export of yeast mutants lacking 
Pry function. Consistent with their activity in 
vivo, MpPR-1d and MpPR-1k bound 
cholesterol in vitro. Interestingly, two the 
MpPR-1 family members that did not bind 
sterols, MpPR-1e and MpPR-1i, bound fatty 
acids in vitro and they also complemented the 
block in fatty acid export of mutant cells 
lacking their endogenous CAP function. Closer 
inspection of the sequence of the CBM of these 
four MpPR-1 proteins revealed that proteins 
that bound sterols have a conserved CBM 
whereas those that did not bind harbored 
substitutions of an aromatic residue at position 
3 of the CBM. Remarkably, single mutations 
within the CBM converted a sterol binder into 
a non-binder and vice versa. These data thus 
substantiate the importance of the CBM for 
sterol binding and they suggest that the number 
of CAP proteins present in M. perniciosa and
their sequence diversity might serve to bind a 
variety of small hydrophobic ligands to 
suppress the immune defense of its host. 
RESULTS
MpPR-1 proteins export sterols in vivo  
To determine whether the CAP proteins from 
the cacao pathogen M. perniciosa could bind 
sterols, we first tested whether they would 
complement a block in sterol export of yeast 
cells lacking their endogenous CAP family 
members Pry1 and Pry2. The yeast Pry proteins 
bind cholesterol in vitro and are required for the 
export of cholesteryl acetate into the culture 
supernatant in vivo (18). To test whether the 
expression of the MpPR-1s in pry1 pry2
double mutant cells rescued the defect in 
cholesterol export, hem1 and say1 (hem1
say1) deficient cells of the indicated genotype 
were cultivated in the presence of radiolabeled 
[14C]-cholesterol overnight. In these 
experiments, heme deficient cells are being 
used because unlike wild-type cells, heme 
mutants can take up sterols form the media. In 
addition, these cells are deficient for the sterol 
deacetylase, Say1, and thus secrete cholesteryl 
acetate into the culture medium (27). Cells were 
then washed and diluted in fresh medium to 
allow the export of cholesterol and cholesteryl 
acetate. Lipids were extracted from the cell 
pellet (P) and the culture supernatant (S), 
separated by thin-layer chromatography (TLC), 
visualized, and quantified by phosphorimaging. 
The relative percentages of cholesteryl acetate 
(CA) that was exported by the cells was plotted 
as an export index (ratio between extracellular 
CA and the sum of intracellular and 
extracellular CA). Mutant yeasts expressing 
MpPR-1c, MpPR-1d, MpPR-1g, MpPR-1j, and 
MpPR-1k exported high levels of CA into the 
culture supernatant, indicating that these 
MpPR-1 genes functionally complement the 
absence of yeast CAP proteins (pry) in vivo
(Fig. 1). The expression of MpPR-1a, MpPR-
1b, MpPR-1e, MpPR-1f, or MpPR-1i, on the 
other hand, failed to rescue the block in sterol 
export. MpPR-1h could not be tested because 
the transformants died after initial growth, 
suggesting that this gene is toxic to yeast 
growth (data not shown). These results thus 
indicate that some but not all of the CAP 
proteins from M. perniciosa could bind sterols 
in vivo.
Sequence analysis of the caveolin-binding motif 
of MpPR-1 proteins  
To understand why some of the CAP proteins 
from M. perniciosa could bind sterols whereas 
other could not, we analyzed their sequence at 
the caveolin-binding motif (CBM). Our 
previous studies had revealed that the CBM is 
important for sterol binding of the yeast Pry1 
protein (24). The hallmark of the CBM is the 
presence of aromatic amino acids in positions 
1, 3, and 8 of the motif (øxøxxxxø) (24, 28, 29). 
While the first aromatic residue is conserved in 
all MpPR-1 proteins, the aromatic residues at 
positions 3 and 8 of the motif are only 
conserved in MpPR-1c, MpPR-1d, MpPR-1g, 
and MpPR-1j, as revealed by the sequence 
alignment shown in Fig. 2. MpPR-1k, has an 
alanine in position 3 of the CBM, which 
appears to be functional for sterol binding. 
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Thus, MpPR-1 family members that bound 
sterols in vivo also had a conserved CBM. 
Conversely, in MpPR-1a, MpPR-1b, MpPR-1e, 
MpPR-1f and MpPR-1i, which failed to 
complement the deficiency in the export of 
cholesteryl acetate, either only position 3 
(MpPR-1a, MpPR-1e) or both positions 
(MpPR-1b, MpPR-1f, MpPR-1i) within the 
CBM contain non-aromatic residues (Fig. 2). 
MpPR-1i is somewhat atypical as the loop 
region containing the CBM appears to be 
shortened, essentially resulting in a deletion of 
the residue in position 8 of the sequence motif 
(Fig. 2).  
Role of the CBM in sterol binding by M. 
perniciosa CAP proteins 
To evaluate the functional importance of the 
aromatic residues at position 3 of the CBM for 
sterol binding, we generated mutations in 
MpPR-d, MpPR-1e, MpPR-1i and MpPR-1k. 
The rationale was to convert non-binding 
MpPR-1 family members into sterol binding 
ones, and vice-versa. To convert MpPR-1d into 
MpPR-1e, tyrosine at position 155 of MpPR-1d 
was mutated to proline (MpPR-1de; MpPR-
1dY155P). To convert MpPR-1e to MpPR-1d, 
proline at position 103 of MpPR-1e was 
mutated to tyrosine (MpPR-1ed; MpPR-
1eP103Y). To convert MpPR-1k to MpPR-1i, 
alanine at position 107 of MpPR-1k was 
mutated to aspartic acid (MpPR-1ki; MpPR-
1kA107D), and to convert MpPR-1i to MpPR-1k 
aspartic acid at position 112 was mutated to 
alanine (MpPR-1ik; MpPR-1iD112A; see Fig. 
2, amino acids boxed in red). The mutants were 
analyzed by the yeast complementation assay 
and results are depicted in Fig. 3. The 
conversion of MpPR-1de and that of MpPR-
1ki by exchanging the aromatic residues in 
position 3 of the CBM to either proline (MpPR-
1de) or aspartic acid (MpPR-1ki) resulted 
in a loss of sterol export. Conversely, the 
introduction of an aromatic residue at position 
3 of the CBM of the non-binding MpPR-1e 
(MpPR-1ed) and the removal of a negatively 
charged aspartic acid in MpPR-1i (MpPR-
1ik), resulted in a gain of sterol export 
phenotype. Thus, non-binding MpPR-1s can be 
converted to sterol binders by the introduction 
of an aromatic residue or alanine at position 3 
of the CBM, whereas a sterol-binding MpPR-1 
can be converted to a non-binder by 
substitution of the aromatic residues at position 
3 of the CBM.  
MpPR-1 proteins bind cholesterol in vitro  
To test more directly whether the MpPR-1 
proteins bind sterols in vitro, MpPR-1d and 
MpPR-1k were expressed as C-terminally 
polyhistidine tagged versions in E. coli and 
they were affinity purified on nickel agarose 
beads. Sterol binding was then assessed using 
increasing concentrations of the radioligand 
[3H]-cholesterol (0-400 pmol) and a constant 
concentration of the purified proteins (100 
pmol). These experiments revealed a 
concentration-dependent increase in 
radioligand binding, indicating that MpPR-1d 
and MpPR-1k bind cholesterol in vitro with 
both proteins displaying saturable binding (Fig. 
4A, B). In accordance with the observation that 
MpPR-1de and MpPR-1ki mutant 
versions lost the capacity to export sterols in
vivo, these mutant versions displayed poor 
cholesterol binding in vitro (Fig. 4A, B). 
MpPR-1e and MpPR-1i, on the other hand, 
which did not complement the sterol export 
phenotype in vivo, also displayed poor binding 
when tested in vitro, thus confirming the results 
of the in vivo experiments (Fig. 4C, D). 
Conversely, the corresponding gain of function 
mutants, MpPR-1ed and MpPR-1ik
displayed an increased affinity for sterols also 
in the in vitro assay. Taken together, these data 
indicate that the sterol export phenotype 
observed in the in vivo assay correlates well 
with the relative affinity of the respective 
MpPR-1 family member for sterols as 
determined in vitro and thus reinforce the 
importance of the aromatic residue in position 
3 of the CBM for sterol binding. 
Sterol binding specificity of MpPR-1d 
To examine the ligand-specificity of MpPR-1d, 
the ability of various steroids to compete with 
radiolabeled cholesterol for binding to MpPR-
1d, the M. perniciosa CAP family member with 
the highest affinity for cholesterol, was 
determined using a competitive binding assays 
(Fig. 5). Addition of unlabeled cholesterol or 
that of cholesteryl acetate (50 and 500 pmol) 
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competed with the radiolabeled cholesterol for 
binding to MpPR-1d, indicating that sterol 
binding is specific. Additionally, both, the plant 
sterol sitosterol and the fungal sterol ergosterol 
efficiently competed with the radiolabeled 
cholesterol for binding to MpPR-1d (Fig. 5). 
These results thus indicate that these MpPR-1 
family members can bind different types of 
sterols including those from plants and fungi. 
MpPR-1 proteins bind fatty acids in vivo and in 
vitro
Given that the horsefly CAP protein, tablysin-
15 and the yeast Pry1 bind fatty acids, we 
finally tested whether the four M. perniciosa
CAP family members, which we analyzed in 
more detail for sterol binding, MpPR-1d, 
MpPR-1e, MpPR-1i, and MpPR-1k would bind 
fatty acids as well (17, 19). Therefore, we first 
tested whether expression of these MpPR-1 
proteins in yeast mutants lacking the two major 
acyl-CoA synthetases, Faa1 and Faa4, in 
addition to Pry1 and Pry2, would result in 
export of fatty acids. faa1 faa4 double 
mutant cells have previously been shown to 
export fatty acids into the culture media and this 
fatty acid export requires the yeast CAP family 
members, the Pry proteins (19, 30). 
Quantification of fatty acids exported from 
pry1 pry2 faa1 faa4 mutant cells revealed 
that the expression of either MpPR-1e or 
MpPR-1i promoted fatty acid export whereas 
export was reduced to basal levels in cells 
expressing either MpPR-1d or MpPR-1k (Fig. 
6A). These data thus indicate that the MpPR-1 
proteins that did not bind or export cholesterol, 
MpPR-1e and MpPR-1i, promoted fatty acid 
export, whereas those MpPR-1 proteins that 
bound and exported cholesterol did not export 
fatty acids, i.e., MpPR-1d and MpPR-1k. 
Fatty acid export by Pry in faa1 faa4 mutant 
cells is essential as a quintuple mutant lacking 
both the acyl-CoA synthetases and all three of 
the Pry proteins is lethal (pry1 pry2 pry3
faa1 faa4) (19). To examine whether 
expression of either one of these MpPR-1 
proteins would rescue the lethality of this 
quintuple mutant strain we tested for loss of a 
URA3 marked plasmid containing FAA1. When 
cultivated on media containing (5-FOA, 5-
fluoroorotic acid), which counterselects for the 
presence of URA3, cells expressing MpPR-1e
or MpPR-1i were able to grow but not those 
expressing MpPR-1d or MpPR-1k. This in vivo
test thus confirms the results of the fatty acid 
export assay and indicates that expression of 
either MpPR-1e or MpPR-1i but not that of 
MpPR-1d or MpPR-1k complements the fatty 
acid export block imposed by the absence of the 
endogenous CAP proteins in yeast (Fig. 6B). 
To test whether these MpPR-1 proteins would 
also bind fatty acid in vitro, polyhistidine-
tagged versions were again expressed in E. coli 
and purified by affinity chromatography. They 
were then incubated with increasing 
concentration of [3H]-palmitic acid and binding 
of the radioligand was quantified. The results of 
this analysis are consistent with the in vivo data 
and indicate that both MpPR-1e and MpPR-1i 
bound fatty acids whereas MpPR-1d and 
MpPR-1k displayed background binding (Fig. 
7A). Thus, the MpPR-1 family members that 
export fatty acids in the in vivo assay also 
bound fatty acids when tested in vitro.
To test whether the mutant versions of these 
proteins could now bind both ligands 
simultaneously, we performed in vitro binding 
assays with [3H]-cholesterol (50 pmol) alone, 
[3H]-palmitic acid (50 pmol) alone, and with 
both radioligands being present simultaneously 
(each at 50 pmol). The presence of both 
radioligands in the binding assay resulted in a 
duplication of the radioactivity associated with 
the proteins, indicating that all three proteins 
tested in this assay, Pry1, MpPR-1ed, and 
MpPR-1ik can bind both fatty acids and 
sterols simultaneously (Fig. 7B). 
To assess the fatty acid chain length specificity 
of MpPR-1i and MpPR-1e, we performed 
competition binding experiments with 
unlabeled fatty acids of various chain length. 
The results of these experiments indicate that 
long chain fatty acids (C16, C18), but not C20
competed with [3H]-palmitic acid for binding to 
these proteins (Fig. 8A). Short- (C10), medium- 
(C12, C14) and very long-chain (C22) fatty acids, 
on the other hand, failed to compete with the 
radioligand. The polyunsaturated arachidonic 
acid, the precursor to eicosanoids, however, 
bound to both MpPR-1i and MpPR-1e. The 
acyl chain substrate preference of MpPR-1i and 
MpPR-1e is thus comparable that that 
5
htt
p:/
/do
c.r
ero
.ch
previously observed for tablysin-15 and Pry1 
(17, 19). 
DISCUSSION 
Witches´ broom disease of cacao is caused by 
M. perniciosa, a hemibiotrophic basidiomycete 
phytopathogen that contains 11 genes from 
CAP superfamily (26). Based on gene 
expression analysis, MpPR-1 genes could have 
roles in M. perniciosa pathogenicity as MpPR-
1c, MpPR-1f, MpPR-1g, MpPR-1h, MpPR-1i
and MpPR-1k had highest expression in green 
broom stage, the hallmark of WBD progression 
(26). CAP homologues of S. cerevisiae are 
required for sterol and fatty acid export in yeast 
and they bind cholesterol and fatty acids in vitro
(18, 19). In the present study, we examined 
whether the MpPR-1 proteins could act as 
sterol and fatty acid binding and export 
proteins. Such studies are not possible in M. 
perniciosa, because transformation of this 
fungus is very inefficient and they are unstable. 
In addition, M. perniciosa cannot be cultivated 
in vitro in its monokaryotic, biotrophic form as 
it rapidly converts to the dikaryotic, 
necrotrophic form, which is not of interest to 
understand its pathogenicity. We thus turned to 
yeast a model lacking endogenous CAP 
proteins for the expression and functional 
characterization of MpPR-1 family members. 
From the yeast complementation assay, two 
classes of MpPR-1 genes could be 
distinguished: the expression of MpPR-1c,
MpPR-1d, MpPR-1g, MpPR-1j and MpPR-1k 
cDNAs rescued the sterol export phenotype of 
yeast mutants lacking their endogenous CAP 
proteins. On the other hand, MpPR-1a, MpPR-
1b, MpPR-1e, MpPR-1f and MpPR-1i failed to 
complement the sterol export phenotype. 
However, expression of the sterol non-binding 
MpPR-1e and MpPR-1i complemented the fatty 
acid export defect of mutant cells lacking their 
endogenous CAP proteins and they bound fatty 
acids in vitro. These data thus indicate that CAP 
proteins can bind various types of small 
hydrophobic compounds such as sterols or fatty 
acids. Whereas the yeast Pry1 protein binds 
both of these ligands by two discrete, non-
overlapping lipid-binding sites (19). The M. 
perniciosa PR-1 proteins, on the other hand, 
bind only one of the two ligands tested here. 
These MpPR-1 proteins, however, might bind 
as yet unidentified ligands and this ligand 
binding and sequestration is likely important 
for the pathogenicity of the fungus under 
specific growth conditions.
However, we find no strict correlation between 
expression of a particular MpPR-1 family 
member during the fungal life cycle and its lipid 
ligand specificity. From the six MpPR-1 genes 
up-regulated in green broom stage (MpPR-1c, 
MpPR-1f, MpPR-1g, MpPR-1h, MpPR-
1i and MpPR-1k), three encode PR-1 proteins 
that bind sterols (MpPR-1c, MpPR-1g, MpPR-
1k) (4). Of the remaining, two encode PR-1 
proteins that bind fatty acids (MpPR-1f, MpPR-
1i) and one could not be tested due to its 
toxicity in yeast (MpPR-1h). From these data, 
it thus seems likely that binding of both sterols 
and fatty acids is important in WBD 
progression. 
The data presented here are consistent with the 
proposition that CAP proteins constitute a class 
of secreted lipid binding proteins and that they 
serve to sequester hydrophobic compounds that 
are secreted by the respective host to modulate 
its immune response. Such a possible mode of 
action of CAP proteins is supported by the 
observation that yeast mutants lacking Pry 
function are hypersensitive to eugenol, a 
member of the alkylbenzene class of 
compounds present in clove oil, nutmeg, 
cinnamon, and bay leaf, used as local antiseptic 
and anesthetic. Importantly, this eugenol 
sensitivity is proportional to expression levels 
of Pry proteins and eugenol competes with 
cholesterol for binding to Pry in vitro,
indicating that the flexible loop harboring the 
CBM can not only bind sterols but also other 
small hydrophobic compounds such as for 
example eugenol, thereby protecting cells from 
its toxicity (18, 23). A possible sequestration-
based mode of action of CAP family members 
in plant innate immunity is supported by the 
fact that plant PR-1 binds sterols in vitro and 
addition of the purified PR-1 protein inhibits 
growth of the sterol-auxotrophic plant 
pathogenic oomycete Phytophthora (21). Thus, 
CAP family members secreted by both the host 
and the pathogen may serve to sequester small 
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hydrophobic compounds required for the 
survival of either one (31, 32). 
M. perniciosa PR-1 proteins harbor a fold that 
is characteristic of all CAP proteins, an alpha-
beta-alpha sandwich fold (26, 33). The sterol-
binding domain within the CAP domain is 
composed of a flexible loop containing 
aromatic amino acids (24). This caveolin-
binding motif is conserved in the MpPR-1 
members that binds sterols, but in members that 
do not bind cholesterol, the CBM contains 
substitutions of the important residues at 
position 3 and 8 of the motif. Remarkably, 
MpPR-1 proteins that failed to bind sterols 
could be converted to sterol binders by the 
exchange of the amino acid in positon 3 of the 
CBM and vice-versa.  
In contrast to the sterol-binding CBM, the 
structural requirements for the fatty acid 
binding pocket are less well defined. The fatty 
acid-binding pocket of tablysin-15 is composed 
of two helices (1 and 3) that run parallel to 
each other and a shorter third helix (4) 
running perpendicular and forming the bottom 
closure of the fatty acid-binding pocket (17). 
Our analysis of fatty acid binding by Pry1 
revealed that a conserved valine (position 254 
of Pry1) at the bottom of the binding grove is 
important for binding fatty acids (19). This 
valine is conserved in MpPR-1e (position 114) 
and substituted by an isoleucine in MpPR-1i 
(position 121), which both bind fatty acids. 
However, this valine is also conserved in 
MpPR-1d (position 170) and substituted by 
alanine in MpPR-1k (position 121), which both 
do not bind fatty acids (Fig. 8B). Thus, to define 
the sequence requirements of this second lipid 
binding pocket, more structural information of 
different MpPR-1 family members will be 
required.  
Taken together, the data presented here show 
that CAP family members from the cacao 
pathogenic fungus, M. perniciosa display 
different lipid-binding properties. Five of the 
ten tested MpPR-1 family members (c, d, g, j, 
k) exported cholesteryl acetate in vivo and two 
of them (d and k) were tested and confirmed to 
bind cholesterol in vitro. In contrast, MpPR-1e 
and MpPR-1i, which did not export sterols, 
bound and exported fatty acids. Remarkably, 
both MpPR-1e and MpPR-1i could be 
converted to sterol binders by a single point 
mutation in their CBM and the respective 
mutant proteins MpPR-1ed and MpPR-1ik 
could simultaneously bind both sterols and 
fatty acids in vitro. Thus, the diversification of 
the CAP family members in M. perniciosa may 
serve to bind a structurally diverse set of 
hydrophobic ligands at defined stages of the 
fungal life cycle. 
EXPERIMENTAL PROCEDURES 
Gene cloning and site-directed mutagenesis 
cDNA was synthesized from 1 μg total RNA 
using the SuperScript II Reverse Transcriptase 
(Invitrogen, Thermo Fisher Scientific, 
Carlsbad, CA, USA), according to the 
manufacturer’s instructions. Primers 
specifically designed for the amplification of 
each MpPR-1 gene, without the peptide signal 
sequence, were used in PCR reactions 
containing cDNA from the basidiomata 
(MpPR-1a, MpPR-1b, MpPR-1d, MpPR-1e and 
MpPR-1j) or green brooms stage of 
development (MpPR-1c, MpPR-1f, MpPR-1g, 
MpPR-1h, MpPR-1i and MpPR-1k). Amplicons 
were subcloned into pGEM T-easy plasmid 
(Promega, Madison, WI, USA) which was 
digested with appropriate restriction enzymes. 
Site-directed mutagenesis was performed by 
PCR using mismatch primers. 
Yeast strains and growth conditions 
Yeast strains were cultivated either in rich 
media (YPD; 1% Bacto yeast extract, 2% Bacto 
peptone, and 2% glucose; US Biological, 
Swampscott, MA) or in minimal media 
(containing 0.67% yeast nitrogen base without 
amino acids (US Biological), 0.73 g/l amino 
acids, and 2% glucose). Media supplemented 
with sterols contained 0.05 mg/ml Tween 80 
and 20 gg/ml cholesterol (Sigma Chemical Co., 
St. Louis, MO). To bypass heme deficiency, 
cells were grown in media supplemented with 
10 gg/ml delta-aminolevulinic acid.  
Expression and purification of MpPR-1 
proteins
MpPR-1 genes and their mutant versions were 
cloned into the NcoI and XhoI sites of pET22b 
vector (Novagen, Merck, Darmstadt, 
Germany), which contains a PelB signal 
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sequence to direct the secretion of the 
expressed protein into the periplasmic space. 
The vector was transformed into Escherichia 
coli BL21 and expression of the polyhistidine-
tagged protein was induced by lactose at 24°C 
overnight. Cells were harvested, lysed, and 
incubated with Ni-NTA beads (Qiagen, Hilden, 
Germany). Beads were washed and proteins 
were eluted with imidazole and quantified. 
Protein concentration was determined by 
Lowry assay using Folin reagent and BSA as 
standard.  
In vivo sterol export assay 
The yeast sterol export assay is based on the 
secretion of cholesterol acetate (CA) into the 
culture supernatant and was performed as 
previously described (27). Yeast mutants 
deficient in heme biosynthesis (hem1) and 
lacking the sterol deacetylase Say1 (say1) 
were cultivated overnight in the presence of 20 
gg/ml cold cholesterol and 0.5% Tween 80. 
Cells were harvested by centrifugation, washed 
twice with synthetic complete (SC) media, 
diluted to an OD600 of 1.0 into fresh media 
containing 0.025 gCi/mL [14C]-cholesterol 
(American Radiolabeled Chemicals, Inc., St. 
Louis, MO) and grown overnight. Cells were 
washed with SC media and cultivated for 
another day with non-radiolabeled cholesterol. 
Cells were centrifuged and lipids were 
extracted from the cell pellet and the culture 
supernatant using chloroform/methanol [1:1, 
(v/v)]. Samples were dried and separated by 
thin-layer chromatography on silica gel 60 
plates (TLC; Merck, Darmstadt, Germany) 
using the solvent system petroleum 
ether/diethyl ether/acetic acid [70:30:2, per 
volume]. TLCs were exposed to 
phosphorimager screens and radiolabeled lipids 
were visualized and quantified using a 
phosphorimager (GE Healthcare, Little 
Chalfont, UK). The export index was 
calculated as the ratio of extracellular CA to the 
sum of intracellular and extracellular CA. 
Export experiments were performed in 
triplicate and the export index is given as the 
mean ± standard deviation of three independent 
experiments. 
Fatty acid export and quantification
Wild-type and mutant cells were grown in SC 
medium at 30°C. Cells were washed once in 
cold water, and a fatty acid standard (C17:0; 50 
μg; Sigma) was added. Cells were disrupted 
using glass beads, and lipids were extracted 
using chloroform/methanol (1:1; per volume) 
for cellular lipids and with 
chloroform/methanol/concentrated HCl (1:2: 
0.03; per volume) for extracellular fatty acids. 
Fatty acid methyl esters (FAMEs) were 
prepared from 5 A600 nm units of yeast cells using 
boron trifluoride at 100 °C for 45 min and were 
recovered by extraction with petrol ether. After 
evaporation, extracts were resuspended in 
hexane. FAMEs were separated with an Agilent 
7890A gas chromatograph (GC) equipped with 
a DB-23 capillary column (30 m 0.25 mm 0.25 
m) (Agilent Technologies, Santa Clara, CA). 
The temperature of the injection port was set to 
250°C, its pressure to 26.24 p.s.i. (average 
velocity, 48.17 cm/s), and the septum purge 
flow to 3 ml/min. Split injections occurred 
through an Agilent 7693A automated liquid 
sampler. The initial oven temperature (100°C; 
held for 2 min) was increased to 160°C at a rate 
of 25°C/min and was then increased again to 
250°C at 8°C/min. The final oven temperature 
was held for an additional 4 min. FAMEs were 
detected with a flame ionization detector 
(Agilent Technologies) set at 270°C with H2, 
air, and helium flows set at 30, 400, and 27.7 
ml/min, respectively. FAMEs were quantified 
relative to the internal standard, and the relative 
response factor for each FAME was determined 
from a four-level calibration curve (r2, 0.999).  
In vitro lipid binding and competition assay 
To determine lipid binding in vitro, a 
radioligand-binding assay was performed as 
described previously (18, 34, 35). Purified 
protein (100 pmol) in binding buffer (20 mM 
Tris, pH 7.5, 30 mM NaCl, 0.05% Triton X-
100) was incubated with [3H]-cholesterol or 
[3H]-palmitic acid (0–400 pmol) for 1 h at 
30°C. The protein was then separated from the 
unbound ligand by adsorption to Q-sepharose 
beads (GE Healthcare); beads were washed 
with washing buffer (20 mM Tris pH 7.5), 
proteins were eluted (20 mM Tris, pH 7.5, 1 M 
NaCl), and the radioligand was quantified by 
scintillation counting. To determine non-
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specific binding, the binding reaction was 
performed without the addition of protein into 
the binding assay. For competition binding 
assays, unlabeled sterols or fatty acids (Sigma 
Chemical Co., St Louis, MO) were included in 
the binding reaction together with an equal 
concentration to the respective radiolabeled 
ligand (50 pmol). 
At least two independent experiments were 
performed under each experimental condition 
and data is reported as the mean ± standard 
deviation. Statistical significance of data was 
analyzed by a multiple Student’s t test (Prism, 
GraphPad Software, La Jolla, CA).  
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FIGURE LEGENDS 
FIGURE 1. Some MpPR-1 family members complement the sterol export defect of yeast mutants 
lacking Pry function. (A) Heme and Say1 deficient double mutant cells (hem1 say1) containing 
either no plasmid (-), an empty plasmid (Empty), a plasmid-borne copy of Pry1 or of the indicated 
MpPR-1 family member were cultivated in the presence of radiolabeled [14C]-cholesterol. Lipids 
were extracted from the cell pellet (P) and the culture supernatant (S), separated by thin layer 
chromatography (TLC) and visualized by phosphorimaging. The position of free cholesterol, FC; 
cholesterly acetate, CA; steryl esters, STE; and that of unidentified lipids * are indicated to the left. 
The experiment was repeated 5-times with similar results. (B) Quantification of the export of 
cholesteryl acetate (CA). The export index indicates the relative levels of CA exported by the cells 
(the ratio between extracellular CA and the sum of intracellular and extracellular CA). Data 
represent mean ± SD of 5 independent experiments. Asterisks denote statistical significance of the 
export phenotype relative to hem1 say1 double mutant cells (***, p < 0.0001). n.s.; not 
significant. 
FIGURE 2. Comparison of the caveolin-binding motif (CBM) of the eleven MpPR-1 family 
members from M. perniciosa. The position of aromatic amino acids (ø) within the CBM is indicated 
at the top. Residues in red squares at position 3 of the motif mark the amino acids that were mutated. 
The aromatic amino acid in position 8 of the CBM is conserved only in few family members. 
Proteins selected for further analysis are highlighted in yellow, MpPR-1d, MpPR-1e, MpPR-1i, and 
MpPR-1k. 
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FIGURE 3. Single point mutations in the CBM convert MpPR-1s that do not export sterols into 
sterol exporters. (A) Substitutions of aromatic amino acids in the third position of the CBM convert 
the sterol exporting MpPR-1d and MpPR-1k into non-exporting mutant versions (MpPR-1de and 
MpPR-1ki). Conversely, introduction of an aromatic residue at position 3 of the CBM results in 
the conversion of the non-sterol exporting MpPR-1e and MpPR-1i into gain of function versions 
(MpPR-1ed and MpPR-1ik). hem1 say1 double mutant cells expressing the indicated wild-
type (wt) or mutant version of MpPR-1 proteins were radiolabeled with [14C]-cholesterol. Lipids 
were extracted from the cell pellet (P) and the culture supernatant (S) and separated by TLC. The 
position of free cholesterol, FC; cholesteryl acetate, CA; steryl esters, STE; and that of an 
unidentified lipid * are indicated to the left. The experiment was repeated 3-times with similar 
results. (B) The export index was plotted as the ration between exported to total CA. Data represent 
mean ± SD of 3 independent experiments. Asterisks denote statistical significance of the export 
phenotype (***, p < 0.0001). 
FIGURE 4. MpPR-1 bind cholesterol in vitro. (A-D) MpPR-1 family members that export sterols 
in vivo also bind sterols in vitro. Sterol binding by the indicated MpPR-1 wild-type (wt) protein 
and the respective mutant versions was assessed using 100 pmol of purified protein and an 
increasing concentration of [3H]-cholesterol (0-400 pmol). The protein was separated from 
unbound ligand by adsorption to an anion-exchange matrix and bound radioligand was quantified 
by scintillation counting. Background binding was recorded by performing the binding assay in the 
absence of protein. Data represent mean ± SD of 3 independent experiments. n.d.; not determined. 
FIGURE 5. MpPR-1d binds cholesteryl acetate, sitosterol and ergosterol in vitro. Binding 
specificity of MpPR-1d was assessed in a competition binding assay in which an unlabeled sterol 
competes with [3H]-cholesterol for binding to the protein. Purified MpPR-1d protein (100 pmol) 
was incubated with 50 pmol of [3H]-cholesterol and either an equal concentration (50 pmol) or an 
excess (500 pmol) of the indicated sterol. Data represent mean ± SD of 2 independent experiments. 
Asterisks denote statistical significance relative to the control containing only the radiolabeled 
cholesterol and purified MpPR-1d (**, p < 0.001; *, p < 0.01).
FIGURE 6. MpPR-1 family members that do not export sterols export fatty acids. (A) Wild-type 
(wt), faa1 faa4 double mutant and pry1 pry2 faa1 faa4 quadruple mutant cells expressing 
the indicated MpPR-1 family members were cultivated in minimal medium overnight at 30°C. 
Lipids were then extracted from the cell pellet and the culture supernatant and fatty acids were 
quantified by GC-MS. Values are plotted as export index representing the amount of exported fatty 
acids relative to total fatty acids present in the cell pellet and the supernatant. Data represent mean 
± SD of 3 independent experiments. Asterisks denote statistical significance relative to the faa1
faa4 double mutant (**, p < 0.001). n.s.; not significant. (B) MpPR-1 family members that do not 
export fatty acids do not provide the essential function of CAP proteins in cells that export fatty 
acids. Wild-type and quintuple mutant cells lacking Pry function and the acyl-CoA synthetases 
Faa1 and Faa4 expressing a plasmid borne copy of either Pry1 or the indicated MpPR-1 family 
member were serially diluted 10-fold and spotted on plates with the indicated media. The URA3-
marked plasmid-borne copy of FAA1 present in these cells cannot be lost on 5-FOA media in cells 
expressing MpPR-1d or MPPR-1k, the two MpPR-1 family members that do not export or bind 
fatty acids. 
FIGURE 7. MpPR-1 family members that export fatty acids in vivo also bind fatty acids in vitro.
(A) Fatty acid binding to the indicated MpPR-1 family members was assessed by an in vitro binding 
assay with purified protein (100 pmol) and an increasing concentration of [3H]-palmitic acid (0-
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400 pmol). The protein was separated from unbound ligand by adsorption to an anion-exchange 
matrix and bound radioligand was quantified by scintillation counting. Background binding was 
recorded by performing the binding assay in the absence of protein. (B) CAP family members can 
bind both sterols and fatty acids simultaneously. Radioligand binding by yeast Pry1 and the 
respective gain of function versions of MpPR-1, MpPR-1ed, and MpPR-1ik, was assessed 
using 100 pmol of purified protein and either [3H]-cholesterol (50 pmol), [3H]-palmitic acid (50 
pmol), or both [3H]-cholesterol and [3H]-palmitic acid (each at 50 pmol) in the binding reaction. 
Data represent mean ± SD of 3 independent experiments. 
FIGURE 8. MpPR-1 family members bind saturated long chain and polyunsaturated fatty acids. 
(A) Fatty acid binding specificity was assessed by a competition binding assay in which an equal 
concentration (50 pmol) of the unlabeled fatty acid of the indicated chain length and degree of 
unsaturation competes with the radiolabeled [3H]-palmitic acid (50 pmol) for binding to the protein 
(100 pmol). Data represent mean ± SD of 3 independent experiments. Asterisks denote statistical 
significance relative to the control containing only the radiolabeled palmitic acid and purified 
MpPR-1i or MpPR-1e, respectively ((***, p < 0.0001; **, p < 0.001; *, p < 0.01). n.s.; not 
significant. (B) Sequence alignment around the fatty acid-binding pocket. The sequence of tablysin-
15, yeast Pry1, and the M. perniciosa MpPR-1 family members analyzed in more detail are shown. 
Numbering on the top corresponds to the amino acid positions in Pry1. Valine at position 254 of 
Pry1 (boxed in green) is important for fatty acid binding (19). Key residues shown in colors are 
those forming the fatty acid binding pocket in tablysin-15 (17). Panel B adapted from (19).
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FIGURE 8 
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